JP6853522B1 - Infectious disease control system - Google Patents

Abstract

PROBLEM TO BE SOLVED: To provide an infectious disease control system for determining admission to a visited place based on the infection risk of an infectious disease of a user. In an infectious disease control system 10, a user terminal 100, a visited terminal 300, and an infectious disease control device 200 for determining admission are connected via a communication line. The user terminal transmits the health management data of the user who has received the input by the physical condition information input receiving means to the infectious disease control device. The infectious disease control device receives health management data and antibody test result information from the user terminal, and when the user terminal requests the issuance of admission check information, the health management data and antibody test result information are used. Based on this, it is determined whether or not the user can enter the visited place, and the admission check information for notifying the result is transmitted to the user terminal. The visited terminal reads the admission check information displayed on the user terminal, and displays information indicating whether or not the user can enter the visited destination based on the information for admission check. [Selection diagram] Fig. 1

Description

The present invention relates to an infectious disease control system.

The following entrance / exit management systems are known. In this entrance / exit management system, the user's body temperature is measured using the thermography provided at the entrance, and when an abnormality is detected in the user's body temperature, the user's entrance is restricted. When a person has a high fever due to influenza, the user is prevented from entering the facility until the entrance is allowed (for example, Patent Document 1).

Japanese Unexamined Patent Publication No. 2011-204062

In the conventional entrance / exit management system, whether or not the user has a high fever is detected by measuring the user's body temperature at the entrance using a sensor such as thermography. However, body temperature at the time of visit may not be sufficient to limit admission to patients with infectious diseases such as viruses. In such a case, if it is possible to determine whether or not the visitor can enter the site by taking into consideration the visitor's daily physical condition and the result of the antibody test in advance, it is possible to accurately identify the infected person and deny the entry. Therefore, it is possible to prevent the spread of infection, but in the conventional system, no study has been made on the technology for that purpose.

The infectious disease control system according to the present invention determines whether or not the user can enter the user terminal operated by the user, the visited terminal installed at the visited destination by the user, and the user's visited destination for infectious disease countermeasures. The infectious disease control device that executes the processing for the infectious disease is connected via a communication line, and the user terminal receives the input by the physical condition information input receiving means that accepts the input of the information about the physical condition from the user and the physical condition information input receiving means. By the health management data transmission means for transmitting the user's health management data including information on the physical condition to the infectious disease control device, the antibody test result identification means for identifying the antibody test result of the user's infectious disease, and the antibody test result identification means. Infectious disease countermeasures when instructed to output the antibody test result information transmission means for transmitting the identified antibody test result information to the infectious disease control device and the admission check information used to determine the admission of the user. The infectious disease control device is equipped with an admission check information requesting means for requesting the issuance of admission check information to the device and an admission check information display means for receiving and displaying the admission check information from the infectious disease control device. A health management data recording means that receives health management data from a user terminal and records it on a storage medium, an antibody test result information recording means that receives antibody test result information from a user terminal and records it on a storage medium, and a user terminal. When the issuance of admission check information is requested, the user's infection risk is determined based on the health management data and the information on the antibody test result, and the admission to the user's visit is determined based on the infection risk. It is provided with an admission check means for determining admission and an admission check information transmitting means for transmitting admission check information for notifying the admission check result of the user's visit destination determined by the admission decision means. , The visited terminal is based on the admission check information reading means for reading the admission check information displayed on the user terminal and the admission check information read by the admission check information reading means. It is equipped with an admission availability information display means that displays information indicating admission availability, and the admission availability determination means includes risks based on the user's basic information and living information, risks based on contact information with infected persons, user symptoms and vital data. For each risk based on the user's vaccination and test results, a score for determining the user's infection risk is calculated, and the total value of the scores calculated for each risk is calculated in advance. It is characterized in that the high risk of infection of a user is determined by comparing with a set threshold value.
The infectious disease control system according to the present invention is also an infectious disease control system for determining whether or not a user can enter a visited place based on the infection risk of the user's infectious disease, and the user inputs information on physical condition. Health when instructed to receive physical condition information input receiving means, antibody test result specifying means for identifying the antibody test result of the user's infectious disease, and output of admission check information used for determining admission of the user. The user's infection risk is determined based on the management data and the information of the antibody test result, and the admission determination means for determining the admission to the user's visit destination based on the infection risk is determined by the admission determination means and the admission determination means. Based on the admission check information issuing means for issuing admission check information for notifying the result of determining whether or not the user can enter the visited place, and the admission check information issued by the admission check information issuing means. It is equipped with an admission information display means that displays information indicating whether the user can enter the visited place, and the admission judgment means is a risk based on the user's basic information and living information, a risk based on contact information with an infected person, and so on. A score for determining the user's infection risk is calculated for each risk based on the user's symptoms and vital data, and the risk based on the user's vaccination and test results, and the sum of the scores calculated for each risk. It is characterized in that the high risk of infection of a user is determined by comparing a value with a preset threshold value.

According to the present invention, it is possible to determine whether or not a visitor can enter the site by taking into consideration the user's daily physical condition and the result of an antibody test in advance, and display the determination result. Therefore, there is a risk of infection at the user's destination. It is possible to prevent the spread of infection by denying the entry of high-ranking users.

It is a block diagram which shows the structure of one Embodiment of an infectious disease control system 10. It is a block diagram which shows the structure of one Embodiment of a user terminal 100. It is a block diagram which shows the structure of one Embodiment of an infectious disease control apparatus 200. It is a block diagram which shows the structure of one Embodiment of a visit terminal 300. FIG. 1 is a diagram schematically showing a test kit for performing an antibody test. FIG. 2 is a second diagram schematically showing a test kit for performing an antibody test. FIG. 3 is a third diagram schematically showing a test kit for performing an antibody test. FIG. 4 is a fourth diagram schematically showing a test kit for performing an antibody test. FIG. 5 is a diagram schematically showing a test kit for performing an antibody test. FIG. 6 is a diagram schematically showing a test kit for performing an antibody test. It is a flowchart which shows the flow of the process executed in the user terminal 100. It is a flowchart which shows the flow of the process executed by the infectious disease control apparatus 200. It is a flowchart which shows the flow of the process executed in the visit terminal 300.

Infectious diseases caused by pathogens such as viruses and bacteria may be transmitted by contact infection or droplet infection, and admission to an unspecified number of people such as event venues, restaurants, department stores, or retail stores. Infection may spread in the expected space. Therefore, in order to prevent the spread of such infectious diseases, visitors enter at places where an unspecified number of people are scheduled to visit, such as event venues, restaurants, department stores, or retail stores. It is effective to determine the infection risk of the visitor before and deny the entrance of the visitor who has a high infection risk. Therefore, the infectious disease control system in the present embodiment provides a mechanism for determining the infection risk of the visitor at the visitor's destination.

FIG. 1 is a block diagram showing a configuration of an embodiment of the infectious disease control system 10 according to the present embodiment. In the infectious disease control system 10, the user terminal 100 owned by the user, the infectious disease control device 200 that executes a process for determining the infection risk of the user's infectious disease, and the visited terminal arranged at the user's visited destination. The 300 is connected via a communication line, for example, the Internet.

As the user terminal 100, for example, a smartphone, a mobile phone, a tablet terminal, a personal computer, or the like is used. FIG. 2 is a block diagram showing a configuration of an embodiment when a smartphone is used as the user terminal 100 in the present embodiment.

The user terminal 100 includes a touch panel 101, a communication module 102, a control device 103, and a camera 104.

The touch panel 101 is an electronic component that combines a display device such as a liquid crystal panel and a position input device such as a touch pad, and is an input device that can operate the device by pressing a display on the screen. For example, the operator of the user terminal 100 can operate the user terminal 100 by touching or sliding display items such as buttons and menus displayed on the liquid crystal panel with a finger or a touch pen. The touch panel 101 detects an operation such as touch or slide by the operator, and outputs the detection signal to the control device 103.

The communication module 102 includes a module for connecting the user terminal 100 to a communication line such as the Internet via a LAN or a mobile phone communication network by wireless or wired. The user terminal 100 can communicate with the infectious disease control device 200 by connecting to the communication line via the communication module 102.

The control device 103 is composed of a CPU, a memory, and other peripheral circuits, and controls the entire user terminal 100. The memory constituting the control device 103 includes, for example, a volatile memory such as SDRAM and a non-volatile memory such as a flash memory. The volatile memory is used as a work memory for the CPU to expand the program when the program is executed and as a buffer memory for temporarily recording data. Further, in the non-volatile memory, the program data of the firmware for operating the user terminal 100 and the software for operating various applications are recorded.

The camera 104 is a known image pickup device including a lens, an image pickup device, and other peripheral circuits. The image and moving image data captured by the camera 104 are output to the control device 103.

The infectious disease control device 200 is a device connected to the Internet, and for example, a personal computer or a server is used. FIG. 3 is a block diagram showing a configuration of one embodiment when a server device is used as the infectious disease control device 200 in the present embodiment. The infectious disease control device 200 includes a connection interface 201, a control device 202, and a storage medium 203.

The connection interface 201 is an interface for connecting the infectious disease control device 200 to a communication line such as the Internet. For example, a wired LAN module for connecting to the Internet by wire or a wireless LAN for wirelessly connecting to the Internet. Modules etc. are used. In the present embodiment, the infectious disease control device 200 communicates with the user terminal 100 and the visited terminal 300 via the connection interface 201.

The control device 202 is composed of a CPU, a memory, and other peripheral circuits, and controls the entire infectious disease control device 200. The memory constituting the control device 202 is, for example, a volatile memory such as SDRAM. This memory is used as a work memory for the CPU to expand the program at the time of program execution and as a buffer memory for temporarily recording data. For example, the data read through the connection interface 201 is temporarily recorded in the buffer memory.

The storage medium 203 is a storage medium for recording various data stored in the infectious disease control device 200, data of a program to be executed by the control device 202, and the like, and is, for example, an HDD (Hard Disk Drive) or an SSD (Solid). State Drive) and the like are used. The program data recorded on the storage medium 203 is recorded and provided on a recording medium such as a CD-ROM or DVD-ROM, or is provided via a network and stores the program data acquired by the operator. By installing it on the medium 203, the control device 202 can execute the program.

As the visited terminal 300, for example, a personal computer, a smartphone, a tablet terminal, or the like is used. FIG. 4 is a block diagram showing a configuration of an embodiment when a smartphone is used as the visited terminal 300.

The visited terminal 300 includes a touch panel 301, a communication module 302, a control device 303, and a two-dimensional code reading device 304.

The touch panel 301 is an electronic component that combines a display device such as a liquid crystal panel and a position input device such as a touch pad, and is an input device that can operate the device by pressing a display on the screen. For example, the operator of the visited terminal 300 can operate the visited terminal 300 by touching or sliding display items such as buttons and menus displayed on the liquid crystal panel with a finger or a touch pen. The touch panel 301 detects an operation such as touch or slide by the operator and outputs the detection signal to the control device 303.

The communication module 302 includes a module for connecting the visited terminal 300 to a communication line such as the Internet via a LAN or a mobile phone communication network by wireless or wired. The visited terminal 300 can communicate with the infectious disease control device 200 by connecting to the communication line via the communication module 302.

The control device 303 is composed of a CPU, a memory, and other peripheral circuits, and controls the entire visited terminal 300. The memory constituting the control device 303 includes, for example, a volatile memory such as SDRAM and a non-volatile memory such as a flash memory. The volatile memory is used as a work memory for the CPU to expand the program when the program is executed and as a buffer memory for temporarily recording data. Further, in the non-volatile memory, the program data of the firmware for operating the visited terminal 300 and the software for operating various applications are recorded.

The two-dimensional code reading device 304 is a known device for reading a two-dimensional code, for example, a QR code (registered trademark). The two-dimensional code reading device 304 may be provided in the visited terminal 300, or may be connected to the visited terminal 300 wirelessly or by wire via a predetermined interface.

In the infectious disease control system 10 according to the present embodiment, the information regarding the user's visit acquired from the system of the user's visit destination such as the event venue, restaurant, department store, or retail store as described above is stored in advance in the infectious disease control device 200. It is assumed that the information is recorded on the storage medium 203 of. The content of the information regarding the user's visit varies depending on the visited place, and includes, for example, the user's name, date of birth, address, visited place name, scheduled visit date and time, seat allocation information of the user's seat, and the like.

For example, if the destination is an event venue, the name, date of birth, address, target event name, event date and time, and the ticket purchased by the user obtained from the event ticket sales system. Seat information is included in the information about the user's visit. If the destination is a restaurant, the name, date of birth, address, reserved store name, reservation date and time, and information on the seat that the user will be seated at the time of eating and drinking obtained from the restaurant reservation system. Is included in the information about the user's visit. If the destination is a retail store, the name, date of birth, address, reserved store name, reservation date and time, and seats that the user will be seated at the time of customer service obtained from the customer service reservation system of the retail store. The information is included in the information about the user's visit.

The user who owns the user terminal 100 routinely inputs information about his / her physical condition into the health management application installed in the user terminal 100. It is assumed that the health management application is acquired by a method such as downloading and is installed in the user terminal 100 in advance.

When using the health management application, the user registers user information about the user at the first startup. The user information includes, for example, information such as the user's name, frigana of the name, gender, date of birth, blood type, height, and weight. In the infectious disease control system 10 of the present embodiment, the user is specified by using the user's name and date of birth. At the user terminal 100, the control device 103 transmits the user information input by the user to the infectious disease control device 200. In the infectious disease control device 200, the control device 202 records the user information received from the user terminal 100 on the storage medium 203.

As the physical condition information regarding one's own physical condition, it is assumed that information necessary for determining the infection risk of the user's infectious disease is input, and in the present embodiment, for example, body temperature, symptomatology, and oxygen saturation (SpO2) are input. It shall be done. The health management application has a function that allows information such as body temperature, symptoms, and oxygen saturation to be input for each of these measurement timings, and when the user measures body temperature and oxygen saturation, the user associates it with the measurement date and time. You can enter data on body temperature and oxygen saturation on the screen. The user can also enter his / her current symptomatology on the screen. In the present embodiment, the user measures body temperature and oxygen saturation at a predetermined frequency such as once a day or multiple times a day, or at a frequency arbitrarily determined by the user, and inputs symptoms. I do. As for the symptom to be input, as an item necessary for determining the infection risk of the infectious disease, an item corresponding to the characteristic symptom of the target infectious disease is set in advance, for example, coughing, nasal juice. Items such as swelling, difficulty breathing, coughing, vomiting or diarrhea, abnormal taste, abnormal olfactory sensation, and less water than usual. The method of inputting the symptom is not particularly limited, but the user may select "Yes" or "No" for each of the above items and input the symptom.

When information on body temperature, symptoms, and oxygen saturation is input by the user, the control device 103 associates the input data with the information on the date and time of input and the user identification information for uniquely identifying the user. The management data is transmitted to the infectious disease control device 200. In the infectious disease control device 200, when the control device 202 of the infectious disease control device 200 receives the user's health management data from the user terminal 100, the received health management data is recorded in the storage medium 203. As a result, the user's health management data is accumulated in the storage medium 203 of the infectious disease control device 200.

In the present embodiment, an antibody test kit for infectious diseases is sent from the user's visit to the user in advance, and the user operates the user terminal 100 to register the antibody test result on the health management application. And. For example, the visit destination of the user sends the antibody test kit to the address included in the above-mentioned information about the visit of the user so that the antibody test kit arrives before the scheduled visit date of the user, for example, about two weeks before. The antibody test kit includes, for example, a puncture needle, a manual describing how to use it, clean cotton, a consent form for the test, and reagents used for the test.

The user performs an antibody test using an antibody test kit at a predetermined timing, for example, the day before the scheduled visit date. The antibody test is performed, for example, by collecting one's own blood using a puncture needle and dropping the collected blood into a predetermined place on the test kit. When the result of the test is found, the user inputs the result on the health management application. In this embodiment, it is assumed that the health management application has a function of determining a positive or negative test result based on an image obtained by taking a test kit. Hereinafter, a positive or negative determination method based on an image obtained by taking a test kit will be described.

FIG. 5 is a diagram schematically showing a test kit for performing a user antibody test in the present embodiment. In the present embodiment, as a test kit for detecting the IgM antibody and the IgG antibody of the virus in the blood using the collected blood as a sample, for example, a test kit as shown in FIG. 5 is used. The test kit shown in FIG. 5 includes a sample and a reagent dropping site 5a for dropping a sample and a reagent for testing an IgM antibody, an IgM judgment result display unit 5b for displaying an IgM antibody judgment result, and an IgM judgment result display unit 5b. A sample and reagent dropping site 5c for dropping a sample and a reagent for testing an IgG antibody, an IgG judgment result display unit 5d for displaying an IgG antibody judgment result, and a test kit for uniquely identifying the test kit. An inspection kit ID display unit 5e on which the inspection kit ID is displayed is arranged.

The IgM determination result display unit 5b and the IgG determination result display unit 5d can determine whether the antibody is positive or negative based on the appearance status of the lines on the confirmation line unit C and the determination line unit T. In the present embodiment, when a line appears in both the confirmation line portion C and the determination line portion T, it is determined to be positive. The positive or negative determination method in the test kit of the present embodiment will be described with reference to FIGS. 6 to 9. The method for determining the antibody test in the present invention is not limited to the examples shown in FIGS. 6 to 9.

When a line appears in the confirmation line portion C of the IgM antibody and the confirmation line portion C of the IgG antibody as shown in FIG. 6, both the IgM antibody and the IgG antibody are determined to be negative. Further, as shown in FIG. 7, when a line appears in the confirmation line portion C of the IgM antibody and the confirmation line portion C of the IgG antibody and a line appears in the determination line portion T of the IgM antibody, the IgM antibody is positive. It is judged. Further, as shown in FIG. 8, when a line appears in the confirmation line portion C of the IgM antibody and the confirmation line portion C of the IgG antibody and a line appears in the determination line portion T of the IgG antibody, the IgG antibody is positive. It is judged. Further, as shown in FIG. 9, when a line appears in the confirmation line portion C of the IgM antibody and the confirmation line portion C of the IgG antibody and a line appears in the determination line portion T of the IgM antibody and the IgG antibody, the IgM antibody And IgG antibody is determined to be positive. As a result of the inspection, if none of the lines appear as shown in FIG. 5 or if the line is applied only to the determination line portion T as shown in FIG. 10, the inspection is judged to be invalid.

After dropping the blood collected from itself onto the IgM sample and reagent dropping site 5a and the IgG sample and reagent dropping site 5c, the user applies the reagent attached to the test kit to the IgM sample and reagent dropping site 5a and IgG sample. And the reagent is dropped onto the reagent dropping site 5c. Then, after a predetermined time until the determination result is obtained, for example, 10 minutes, the user can instruct the reading of the test kit to determine the result of the antibody test on the health management application.

When the control device 103 is instructed to determine the result of the antibody test, the control device 103 activates the camera 104 to take a picture of the test kit. Then, the control device 103 determines the result of the antibody test by determining the appearance status of the lines in the IgM determination result display unit 5b and the IgG determination result display unit 5d based on the image of the test kit obtained by photographing. To do. That is, the control device 103 determines the appearance status of the lines in the confirmation line unit C and the determination line unit T of the IgM determination result display unit 5b and the IgG determination result display unit 5d by image processing, and uses FIGS. 5 to 10 to determine the appearance status of the lines. The positive or negative of the user's IgM antibody and IgG antibody is determined based on the determination method described. In addition, the inspection kit ID displayed in the inspection kit ID display unit 5e is read from the captured image. In addition, a process for determining at which position of the confirmation line portion C and the determination line portion T of the IgM determination result display unit 5b and the IgG determination result display unit 5d in the captured image, and an inspection kit. Since a known image processing technique can be used for the process for reading the inspection kit ID displayed in the ID display unit 5e, detailed description thereof will be omitted here.

When the control device 103 determines the result of the antibody test, the control device 103 displays the determination result on the touch panel 101 and transmits the test result information including the determination result to the infectious disease control device 200. The test result information includes, for example, user identification information for identifying a user, information indicating a test result of an IgM antibody and an IgG antibody, and information on a test kit ID.

In the infectious disease control device 200, when the control device 202 receives the user's test result information from the user terminal 100, the control device 202 records the received test result information in the storage medium 203. As a result, test result data indicating the result of the user's antibody test is registered in the storage medium 203 of the infectious disease control device 200. At this time, if the user's preliminary inspection determines that the inspection is invalid, that is, if the IgM determination result display unit 5b and the IgG determination result display unit 5d are in the states shown in FIGS. 5 and 10. Information indicating that the pre-inspection has failed is recorded as the user's inspection result data.

When the control device 202 receives the user's test result information from the user terminal 100, the report of the antibody test result from the user terminal 100 is incorrect based on the test kit ID included in the test result information. You may want to check for it. For example, the inspection kit ID of the inspection kit sent to the user in advance is recorded in the storage medium 203, and the control device 202 is included in the inspection result information in the inspection kit ID recorded in the storage medium 203. If there is a match with the test kit ID, it is determined that there is no problem in reporting the antibody test result from the user terminal 100, and the test kit ID recorded in the storage medium 203 is included in the test result information. If there is no match with the test kit ID, it may be determined that the report of the antibody test result from the user terminal 100 is invalid.

As described above, the user registers the health management data and the test result data in the infectious disease control device 200 in advance, and then visits the visited destination with the user terminal 100 on the day of the visit. At the destination, an antibody test site is prepared for visitors who have failed the antibody test in advance, and users who have failed the antibody test in advance perform antibody tests using the antibody test kit described above. be able to.

The antibody test at the visited place may be carried out, for example, by installing a tent for the antibody test in the vicinity of the visited place. The antibody test tent is designed to lower the air pressure inside the tent from the outside by connecting a negative pressure filter system to prevent the spread of viruses and the like brought in by the user undergoing the antibody test to the outside. In addition, by creating an air flow in the tent to ventilate, an environment is created in which the medical staff performing the examination is less likely to get infected.

The result of the antibody test at the visited place is determined by the control device 103 by taking an image of the test kit with the user terminal 100, as in the case of the pre-test described above. When the control device 103 is instructed to determine the result of the antibody test, the control device 103 activates the camera 104 to take a picture of the test kit. Then, the control device 103 determines the result of the antibody test by determining the appearance status of the lines in the IgM determination result display unit 5b and the IgG determination result display unit 5d based on the image of the test kit obtained by photographing. To do. Then, the control device 103 displays the determination result on the touch panel 101, and transmits the test result information including the determination result to the infectious disease control device 200. In the infectious disease control device 200, the control device 202 records the test result information received from the user terminal 100 on the storage medium 203 after performing the fraud determination based on the test kit ID.

At the visit destination, a thermography gate for measuring the body temperature of the visitor is installed at the entrance, and the body temperature of the user is measured here. The person in charge at the visit confirms whether the body temperature measured by the thermography gate is equal to or higher than a predetermined threshold value set in advance. Here, the threshold value used when confirming the body temperature is assumed to be a preset body temperature suspected of being infected with an infectious disease, and is, for example, 37.5 degrees in the present embodiment.

When the body temperature of the visitor is less than 37.5 degrees, the person in charge of the visit destination confirms whether or not the user who is the visitor can enter by using the admission check application installed in the visit destination terminal 300. Hereinafter, a method for confirming the admission of the user using the admission check application will be described.

The user who is a visitor operates the user terminal 100 to display a two-dimensional code for the entrance check on the touch panel 101 as the entrance check information used for determining whether or not the user can enter. When the user instructs the control device 103 to display the two-dimensional code, the control device 103 requests the infectious disease control device 200 to issue the two-dimensional code for admission check.

In the infectious disease control device 200, when the user terminal 100 requests the issuance of the two-dimensional code for the admission check, the control device 202 visits as admission check information for notifying the admission / rejection determination result. A two-dimensional code for admission check including information on the destination name and the determination result of admission is generated and transmitted to the user terminal 100. Here, the visit destination name may be obtained from the above-mentioned information regarding the user's visit recorded in the storage medium 203. In addition, the process for determining admission, which is executed by the infectious disease control device 200, is as follows.

In the present embodiment, the control device 202 executes the process described below to determine the infection risk of the user's infectious disease. The infection risk is determined in three stages of high, medium, and low, and the control device 202 determines that a user with a high infection risk, for example, a user with a high infection risk cannot enter, and a user with a low infection risk. For example, a user who is determined to have a medium or low infection risk is determined to be admitted. Of the various information used in the risk determination process described below, the data registered in the above process will be used, and the other data will be input in advance by the user on the health management application. It is assumed that the information is recorded as information for each user on the storage medium 203 of the infectious disease control device 200.

In the present embodiment, the control device 202 is used for risks based on the user's basic information and living information, risks based on contact information with an infected person, risks based on the user's symptoms and vital data, and user vaccination and test results. Based risk Determine the risk of infection for a user's infection based on each risk. Specifically, the control device 202 determines the infection risk of the user by calculating the score for determining the infection risk as follows.

In this embodiment, an example of adding or subtracting points for each risk factor described below will be described, but the risk factors are not limited to the following examples and are set according to the characteristics of the infectious disease. .. That is, in the present embodiment, an infectious disease is assumed in which the user's infection risk can be accurately determined by adding or subtracting a preset number of points for each of the following risk factors, but the set risk factors are set. The number of points according to each risk factor is set differently for each infectious disease, and the risk factor used for determining the infection risk and the number of points set are not limited to the following contents.

Risks based on the user's basic information and living information are based on the user's gender, age, medical history, daily exercise time, smoking, drinking, and sleeping time as risks according to the characteristics of the infectious disease. Then, the control device 202 calculates a score for determining the infection risk, for example, as follows. If there is a characteristic that the infected person is biased to a specific gender, a predetermined predetermined point is added to the score when the user has a high possibility of infection. If there is a characteristic that there are many infected persons over a predetermined age, a preset predetermined point is added to the score when the user is over that age. If there is a characteristic that there is a high possibility of infection when the user has a specific medical history, a predetermined predetermined point set in advance when the user has the medical history is added to the score. Specific medical history may include, for example, respiratory disease, cardiovascular disease, diabetes, or cancer. If there is a feature that the possibility of infection is low when the average daily exercise time is longer than the predetermined time, a predetermined point set in advance when the average daily exercise time of the user is longer than the predetermined time. Is subtracted from the score. If there is a characteristic that there is a high possibility of infection when smoking habitually, a predetermined predetermined point set in advance when the user smokes habitually is added to the score. If there is a characteristic that there is a high possibility of infection when the amount of drinking is large, the user's drinking situation is that the number of times of drinking per week is equal to or more than a predetermined threshold and the amount of drinking (ml) per time is equal to or more than a predetermined threshold. In some cases, preset points are added to the score. If the daily sleep time is less than the specified time, there is a high possibility of infection, and if the user's daily sleep time is less than the specified time, a preset predetermined point is used as the score. to add.

The risk based on the contact information of the user with the infected person is scored by the control device 202, for example, as follows, depending on the high possibility of contact with the positive patient. If there are positive patients in the family within 2 weeks, preset points will be added to the score. If there are positive patients within the two seats of the event, preset points will be added to the score. If there is a positive patient in one seat of the event, a predetermined point set in advance is added to the score. If the user always wears a mask when going out, a preset predetermined point is subtracted from the score. If the user is trying to wash his hands, a preset predetermined point is subtracted from the score. If the user wears a face shield when going out, a preset predetermined point is subtracted from the score. When the user uses public transportation for commuting to work or school, preset points are added to the score. If the number of people that the user has contacted when going out is greater than or equal to the predetermined number, preset predetermined points are added to the score. If the number of positives per 1,000 people exceeds a predetermined threshold, preset predetermined points are added to the score.

The risk based on the user's symptomatology and vital data is scored by the control device 202 according to the risk according to the characteristics of the virus, for example, as follows. If you have a cough, add preset points to your score. If you have a runny nose, add preset points to your score. If breathing is difficult, preset points are added to the score. When coughing, preset points are added to the score. If SpO2 is less than 95%, preset predetermined points are added to the score. If SpO2 is less than 95% for more than 2 days within 2 weeks, preset points will be added to the score. If the body temperature is 1.5 degrees or more higher than usual, preset points will be added to the score. If the body temperature continues to be 37.5 degrees or higher for 2 days or more within the last 2 weeks, preset points will be added to the score. If you have vomiting or diarrhea, add preset points to your score. If there is an abnormality in taste, preset points are added to the score. If there is an abnormality in the sense of smell, preset points are added to the score. If the water cannot be taken more than usual, a preset predetermined point is added to the score.

The risk based on the user's vaccination and test results is scored by the control device 202 as follows, for example. Regarding the risk based on the user's vaccination and test results, any one of the following A to H, which corresponds to A to G, is subject to addition and subtraction. If multiple items from A to G are applicable, the item with the highest priority is adopted. Here, it is assumed that A has the highest priority, B, C, D, E, and F have the lowest priority, and G has the lowest priority.
A: If the result of the PCR test performed within 1 week is positive, preset predetermined points are added to the score.
B: If the result of the antigen test performed within 1 week is positive, preset predetermined points are added to the score.
C: If the result of the antibody test performed within 2 weeks is that the IgM antibody is positive and the IgG antibody is negative, a predetermined predetermined point is added to the score.
D: If the result of the antibody test performed within 2 weeks is that both the IgM antibody and the IgG antibody are positive, a predetermined predetermined point is added to the score.
E: If the result of the PCR test performed within 1 week is negative, a preset predetermined point is subtracted from the score.
F: If the result of the antigen test performed within 1 week is negative, a preset predetermined point is subtracted from the score.
G: If the result of the antibody test performed within half a year is that the IgM antibody is negative and the IgG antibody is positive, a predetermined predetermined point is subtracted from the score.
H: After the test result of E or F or G, if the body temperature has not been 37.5 degrees or more for 2 days or more and the SpO2 has not been less than 95% for 2 days or more, a predetermined predetermined value set in advance. Subtract points from the score.
I: If the patient has been vaccinated in the past, a preset predetermined point is subtracted from the score.

In this embodiment, scores are added or subtracted as follows, for example. The score addition / subtraction example shown below is an example, and the number of points to be added / subtracted is set according to the infectious disease targeted by the infectious disease control system 10.

Regarding risks based on the user's basic information and living information, 1 point is added when the gender is male, 2 points are added when the age is 65 years or older, and there is a respiratory disease in the medical history. Add 2 points to, add 2 points if you have a cardiovascular disease in your medical history, add 2 points if you have diabetes in your medical history, and add 2 points if you have cancer in your medical history. Add, subtract 3 points if you are exercising for an average of 1 hour or more a day, add 3 points if you smoke habitually, and drink 500 ml or more 3 times a week or more. In some cases, 1 point shall be added, and if sleep is less than 6 hours a day, 1 point shall be added.

Regarding the risk based on the contact information of the user with the infected person, 10 points will be added if there are positive patients in the family within 2 weeks, and 3 points will be added if there are positive patients within 2 seats. However, 5 points are added when there is a positive patient in one seat, 3 points are subtracted when always wearing a mask when going out, and 3 points are subtracted when trying to wash hands. 3 points will be deducted when the face shield is attached when going out, 3 points will be added when using public transportation for commuting to work or school, and 3 points will be added when the number of contacts when going out is 30 or more. Is added, and 3 points are added when the number of positive persons per 1000 population exceeds 10.

For risks based on user symptoms and vital data, add 5 points for coughing, 2 points for nasal discharge, 5 points for difficulty breathing, and 5 for coughing. Add points, add 5 points when SpO2 is less than 95%, add 3 points when SpO2 is less than 95% for 2 days or more within 2 weeks, and body temperature is 1. 5 points are added when the temperature is 5 degrees or higher, 3 points are added when the body temperature is 37.5 degrees or higher for 2 days or more within the last 2 weeks, and 2 points are added when the body temperature is vomiting or diarrhea. Add 3 points if you have a taste abnormality, add 5 points if you have an odor abnormality, and add 2 points if you can't get more water than usual.

Regarding the risk based on the user's vaccination and test results, 30 points are added for A, 30 points are added for B, 20 points are added for C, and 15 points are added for D. Add, 20 points for E, 15 points for F, 10 points for G, 5 points for H, 10 points for I Subtract.

The control device 202 determines that the infection risk is high when the total value of the risk determination scores calculated by the above processing is equal to or greater than the threshold value for determining the infection risk is high. In addition, if the judgment score is less than the threshold value for judging that the infection risk is low, the infection is judged to be low risk. If the judgment score is equal to or higher than the threshold for determining low infection risk and less than the threshold for determining high infection risk, it is determined to be at infection risk. For example, when the threshold for determining the high infection risk is 30, and the determination score is 9, the threshold for determining the low infection risk is 9, the control device 202 determines the user calculated in the above process. If the score is 30 points or more, it is judged that the infection risk is high, if it is 10 points or more and less than 29 points, it is judged that the infection risk is high, and if it is less than 9 points, it is judged that the infection risk is low.

In the user terminal 100, the control device 103 displays the two-dimensional code received from the infectious disease control device 200 on the touch panel 101. The user holds the two-dimensional code displayed on the touch panel 101 over the two-dimensional code reading device 304 of the visited terminal 300. At the visited terminal 300, an admission check application for confirming whether or not a visitor can enter is executed in advance, and when the control device 303 reads the two-dimensional code via the two-dimensional code reading device 304, the read information is read. Based on the admission determination result included in the above, information indicating whether the user can enter the visited destination is displayed on the touch panel 301.

The person in charge of the visit permits the user to enter if the displayed judgment result is admission, and refuses the user's admission if the displayed judgment result is not admission. As a result, even if the user's body temperature measured by the thermography gate is lower than the body temperature suspected of being infected with an infectious disease, admission is denied if the infection risk determined by the infectious disease control device 200 is high. , It is possible to prevent the spread of infectious diseases at the visited place.

On the other hand, if the visitor's body temperature is 37.5 degrees or higher as a result of the temperature measurement at the thermography gate, the person in charge of the visit will carry out an antigen test for the infectious disease on the user who is the visitor. Also. Even if the visitor's temperature is less than 37.5 degrees as a result of the temperature measurement at the thermography gate, the antibody test is performed to check whether the user's temperature has been 37.5 degrees or more twice or more in the past two weeks. As a result, even when either the IgM antibody or the IgG antibody is positive, the infectious disease antigen test will be performed on the visiting user. The result of the user's antigen test is transmitted to the infectious disease control device 200 and registered by being recorded in the storage medium 203.

The user's antigen test may be performed by stopping a vehicle equipped with equipment for the antigen test, for example, an antigen test bus, in the vicinity of the visited place. There are various mechanisms in the bus to prevent infection, such as medical staff collecting user samples with gloves attached to the holes in the barrier and spraying bacteria after each test. It has a structure that protects subjects and medical staff from infection.

After registering the result of the user's antigen test, the user operates the user terminal 100 to display the two-dimensional code for admission check on the touch panel 101. When the user instructs the control device 103 to display the two-dimensional code, the control device 103 requests the infectious disease control device 200 to issue the two-dimensional code for admission check.

In the infectious disease control device 200, when the user terminal 100 requests the issuance of a two-dimensional code for admission check, the control device 202 takes into account the results of the newly registered antigen test and allows admission as described above. Is performed, a two-dimensional code for admission check including information on the name of the visited place and the judgment result of admission is generated and transmitted to the user terminal 100. In this case as well, the person in charge of the visit permits the user to enter if the displayed judgment result is admission, and refuses the user's admission if the displayed judgment result is not admission. As a result, even if the body temperature of the user is higher than the body temperature suspected of being infected with an infectious disease, the admission of a user who does not have a high risk of infection with an infectious disease determined by the infectious disease control device 200 can be permitted. .. In addition, a user whose body temperature is higher than the body temperature suspected of being infected with an infectious disease and whose infection risk is high as determined by the infectious disease control device 200 refuses admission and is infected with the infectious disease at the visited place. Expansion can be prevented.

In the infectious disease control system 10 of the present embodiment, the health management application installed on the user terminal 100 is equipped with a function for the user to consult a doctor or the like for health. For example, users can talk with doctors and nurses through chats and video calls to discuss their health. At this time, if the user is found to be positive for the infectious disease, the information indicating that the user is positive may be registered in the infectious disease control device 200.

Further, in the infectious disease control system 10 of the present embodiment, the health management application installed on the user terminal 100 displays the information of the body temperature, the symptom, and the oxygen saturation input by the user in chronological order, or in the past. It also has a function to display the results of the antibody test, antigen test, and PCR test received in chronological order. For example, by displaying the body temperature, symptoms, oxygen saturation, antibody test results, antigen test results, and PCR test results by date in a graph or list, the user can display this information in chronological order. You can check.

FIG. 11 is a flowchart showing a flow of processing executed by the user terminal 100 in the present embodiment. The process shown in FIG. 11 is executed by the control device 103 as a program to be started when the user terminal 100 is instructed to execute the above-mentioned health management application. In the process shown in FIG. 11, it is assumed that the above-mentioned information about the user's visit and the user information are recorded in advance in the storage medium 203 of the infectious disease control device 200.

In step S10, the control device 103 determines whether or not the physical condition information such as the body temperature, the symptom, and the oxygen saturation has been input by the user as described above. If a negative determination is made in step S10, the process proceeds to step S30, which will be described later. On the other hand, if an affirmative decision is made in step S10, the process proceeds to step S20.

In step S20, the control device 103 provides health management data in which the physical condition information data input by the user, the input date and time information, and the user identification information for uniquely identifying the user are associated with the infectious disease control device 200. Send to. Then, the process proceeds to step S30.

In step S30, the control device 103 determines whether or not the result determination of the antibody test has been instructed by the user. If a negative determination is made in step S30, the process proceeds to step S70, which will be described later. On the other hand, if an affirmative decision is made in step S30, the process proceeds to step S40.

In step S40, as described above, the control device 103 activates the camera 104 to photograph the inspection kit, and based on the image of the inspection kit obtained by photographing, the IgM determination result display unit 5b and the IgG determination result display unit The result of the antibody test is determined by determining the appearance status of the line in 5d. Then, the process proceeds to step S50.

In step S50, the control device 103 displays the determination result of the antibody test on the touch panel 101. Then, the process proceeds to step S60.

In step S60, as described above, the control device 103 transmits the test result information including the determination result of the antibody test to the infectious disease control device 200. Then, the process proceeds to step S70.

In step S70, the control device 103 determines whether or not the user has instructed to display the above-mentioned two-dimensional code for the entrance check. If a negative determination is made in step S70, the process proceeds to step S110, which will be described later. On the other hand, if an affirmative decision is made in step S70, the process proceeds to step S80.

In step S80, the control device 103 requests the infectious disease control device 200 to issue a two-dimensional code for admission check. Then, the process proceeds to step S90.

In step S90, the control device 103 determines whether or not the two-dimensional code for admission check has been received from the infectious disease control device 200. If an affirmative decision is made in step S90, the process proceeds to step S100.

In step S100, the control device 103 displays the two-dimensional code received from the infectious disease control device 200 on the touch panel 101. Then, the process proceeds to step S110.

In step S110, the control device 103 determines whether or not the end of the health management application has been instructed. If a negative determination is made in step S110, the process returns to step S10. On the other hand, if an affirmative determination is made in step S110, the process ends.

FIG. 12 is a flowchart showing a flow of processing executed by the infectious disease control device 200 according to the present embodiment. The process shown in FIG. 12 is executed by the control device 202 as a program that is started when the software for the infectious disease control system that operates in the infectious disease control device 200 is executed. The execution of the software for the infectious disease control system may be instructed by the operator, or may be automatically instructed when the power of the infectious disease control device 200 is turned on. Alternatively, it may be executed when other start conditions are met. In the process shown in FIG. 12, it is assumed that the above-mentioned information about the user's visit and the user information are recorded in advance in the storage medium 203 of the infectious disease control device 200.

In step S210, the control device 202 determines whether or not the above-mentioned user health management data has been received from the user terminal 100. If a negative determination is made in step S210, the process proceeds to step S230, which will be described later. On the other hand, if an affirmative decision is made in step S210, the process proceeds to step S220.

In step S220, the control device 202 records the received health management data on the storage medium 203. Then, the process proceeds to step S230.

In step S230, the control device 202 determines whether or not the above-mentioned user inspection result information has been received from the user terminal 100. If a negative determination is made in step S230, the process proceeds to step S250, which will be described later. On the other hand, if an affirmative decision is made in step S230, the process proceeds to step S240.

In step S240, the control device 202 records the received inspection result information on the storage medium 203. Then, the process proceeds to step S250.

In step S250, the control device 202 determines whether or not the user terminal 100 has requested the issuance of the above-mentioned two-dimensional code for the entrance check. If a negative determination is made in step S250, the process proceeds to step S290, which will be described later. On the other hand, if an affirmative decision is made in step S250, the process proceeds to step S260.

In step S260, as described above, the control device 202 calculates a score for determining the infection risk, and compares the calculated score with a preset threshold value to increase the infection risk to high, medium, and low. Judgment is performed in three stages, and a user with a high infection risk is prohibited from entering, and a user with a medium and low infection risk is allowed to enter. Then, the process proceeds to step S270.

In step S270, as described above, the control device 202 generates a two-dimensional code for admission check including the information of the visit destination name and the determination result of admission. Then, the process proceeds to step S280.

In step S280, the control device 202 transmits the generated two-dimensional code for admission check to the user terminal 100. Then, the process proceeds to step S290.

In step S290, the control device 202 determines whether or not the result of the user's antigen test has been received. If a negative determination is made in step S290, the process proceeds to step S310, which will be described later. On the other hand, if an affirmative judgment is made in step S290, the process proceeds to step S300.

In step S300, the control device 202 records the received antigen test result information on the storage medium 203. Then, the process proceeds to step S310.

In step S310, the control device 202 determines whether or not the termination condition of the software for the infectious disease control system is satisfied. It may be determined that the termination condition of the software for the infectious disease control system is satisfied when the operator instructs the termination, or it may be determined that the termination condition is satisfied when the power of the infectious disease control device 200 is turned off. Good. Alternatively, other termination conditions may be preset. If a negative determination is made in step S310, the process returns to step S210. On the other hand, if an affirmative determination is made in step S310, the process ends.

FIG. 13 is a flowchart showing the flow of processing executed by the visited terminal 300 in the present embodiment. The process shown in FIG. 13 is executed by the control device 303 as a program to be started when the visited terminal 300 is instructed to execute the above-mentioned entrance check application.

In step S410, the control device 303 determines whether or not the two-dimensional code has been read via the two-dimensional code reading device 304. If a negative determination is made in step S410, the process proceeds to step S430 described later. On the other hand, if an affirmative decision is made in step S410, the process proceeds to step S420.

In step S420, the control device 303 touches the touch panel with information indicating whether or not the user can enter the visited destination based on the information of the admission permission determination result included in the two-dimensional code read through the two-dimensional code reading device 304. Displayed on 301. Then, the process proceeds to step S430.

In step S430, the control device 303 determines whether or not the end of the admission check application has been instructed. If a negative determination is made in step S430, the process returns to step S410. On the other hand, if an affirmative decision is made in step S430, the process ends.

According to the embodiment described above, the following effects can be obtained.
(1) In the user terminal 100, the control device 103 receives an input of information on the physical condition from the user, transmits the user's health management data including the information on the physical condition that has received the input to the infectious disease control device 200, and causes the user to input the information. When the infectious disease antibody test result is specified, the identified antibody test result information is transmitted to the infectious disease control device 200, and the output of the admission check information used for determining the admission of the user is instructed. The infectious disease control device 200 was requested to issue a two-dimensional code as admission check information, and the infectious disease control device 200 received the admission check two-dimensional code and displayed it on the touch panel 101. In the infectious disease control device 200, the control device 202 receives the health management data from the user terminal 100 and records it on the storage medium 203, receives the information on the antibody test result from the user terminal 100 and records it on the storage medium 203. When the user terminal 100 requests the issuance of a two-dimensional code for admission check, it is determined whether or not the user can enter the visited place based on the health management data and the information of the antibody test result, and the determined user's visit. A two-dimensional code for notifying the result of the determination of admission is transmitted to the user terminal 100. The visit destination terminal 300 reads the two-dimensional code for admission check displayed on the user terminal 100, and the control device 303 determines whether or not the user can enter the visit destination based on the read two-dimensional code for admission check. The information to be shown is displayed. In this way, the admission of the user to the visited place is determined based on the health management data and the antibody test result information, so the user's daily physical condition and the result of the antibody test in advance are taken into consideration. It is possible to accurately determine whether or not a visitor can enter. In addition, since it is possible to deny the entry of the user who is determined to be inaccessible at the visited place, it is possible to prevent the spread of infection at the visited place.

(2) The control device 103 is designed to identify the antibody test result of the user's infectious disease based on the image taken of the antibody test kit displaying the test result. As a result, the user can easily determine the result of the antibody test simply by taking a picture of the test kit with a camera after performing the test.

(3) The control device 202 determines the infection risk of the user based on the health management data and the information of the antibody test result, and determines whether or not the user can enter the visited place based on the infection risk. As a result, it is possible to determine whether or not to enter the visited destination based on the infection risk of the user.

(4) The control device 202 calculates a score for determining the infection risk of the user based on the health management data and the information of the antibody test result, and compares the score with a preset threshold value. The high risk of infection of the user is judged. As a result, if points to be added or subtracted to the score are set for each risk factor for determining the infection risk, the infection risk can be determined with high accuracy. In addition, since the risk factors differ depending on the characteristics of the infectious disease, the accuracy of determining the infection risk can be improved by setting the risk factors for determining the infection risk according to the characteristics of the infectious disease. Furthermore, when the degree of influence of each risk factor on the judgment of infection risk is different, the infection risk is judged by taking into account the degree of influence of each risk factor by changing the number of points for score calculation assigned to each risk factor. can do.

(5) The control device 202 determines that the user cannot enter when the user's infection risk is high, and determines that the user can enter when the user's infection risk is low. As a result, it is possible to deny the entry of users with a high risk of infection and prevent the spread of infection at the visited place.

(6) The control device 202 determines whether or not the user can enter the visited place in consideration of the result of the antigen test received by the user and the result of the PCR test. As a result, it is possible to accurately determine whether or not to enter the visited place by taking into account various test results regarding infectious diseases.

(7) The control device 303 reads the entrance check information by reading the two-dimensional code displayed on the touch panel 101 of the user terminal 100. As a result, the user can receive an admission check simply by holding the two-dimensional code over the two-dimensional code reading device 304.

(8) The user terminal 100 can display information on the physical condition of the user and information on the antibody test result in chronological order based on the health management data and the information on the antibody test result. This allows the user to check information on his / her physical condition and information on antibody test results in chronological order on the health management application.

-Modification example-
The infectious disease control system of the above-described embodiment can also be modified as follows.
(1) In the above-described embodiment, the user measures the body temperature and oxygen saturation, operates the user terminal 100, and inputs the data of the body temperature and oxygen saturation on the screen. However, the user may be equipped with a wearable terminal capable of measuring the body temperature and oxygen saturation, and the wearable terminal may measure the user's body temperature and oxygen saturation at a preset timing. In this case, if the user terminal 100 and the wearable terminal are set to be communicable in advance, the user's body temperature and oxygen saturation can be automatically measured and input to the health management application of the user terminal 100. Even when it is necessary to include information other than body temperature and oxygen saturation in the health management data, various health management data can be automatically measured by using a wearable terminal capable of measuring such data. Further, the measurement of the user's body temperature and oxygen saturation is not limited to the type of the device or terminal used for the measurement and the measurement method as long as it is a device or terminal capable of measuring these.

(2) In the above-described embodiment, an example has been described in which the health management application has a function of determining a positive or negative test result based on an image obtained by taking a test kit. However, the result of the antibody test may be determined by the user based on the determination method described in the manual, and the determination result may be manually input on the screen of the health management application.

(3) In the above-described embodiment, the control device 202 of the infectious disease control device 200 is based on the risk based on the basic information and living information of the user, the risk based on the contact information with the infected person, the symptom of the user, and the vital data. The risk of infection for the user's infectious disease shall be determined based on each risk of risk and risk based on the user's vaccination and test results. Specifically, the score set for each item for determining the infection risk. An example of determining a user's infection risk by adding or subtracting and calculating a determination score has been described. However, the items for determining the infection risk are not limited to the above-mentioned examples as long as the items can accurately determine the infection risk of the infectious disease according to the characteristics of the infectious disease.

(4) In the above-described embodiment, the infection risk is determined in three stages of high, medium, and low, and the control device 202 is entered by a user having a high infection risk, for example, a user having a high infection risk. An example of determining that an admission is possible for a user who is determined to be impossible and has a low infection risk, for example, a user who is determined to have a medium or low infection risk has been described. However, the method of determining admission according to the risk of infection is not limited to this. For example, a user with a high infection risk and a medium risk may be determined to be unable to enter, and a user with a low infection risk may be determined to be admitted. Further, the determination of infection risk is not limited to three stages of high, medium, and low. For example, the determination of infection risk is two stages of high and low, and the control device 202 determines that the user has a high infection risk. A user who is determined to be inaccessible and has a low risk of infection may be determined to be admitted.

The present invention is not limited to the configuration in the above-described embodiment as long as the characteristic functions of the present invention are not impaired. Further, the configuration may be a combination of the above-described embodiment and a plurality of modified examples.

10 Infectious disease control system 100 User terminal 101 Touch panel 102 Communication module 103 Control device 104 Camera 200 Infectious disease control device 201 Connection interface 202 Control device 203 Storage medium 300 Visited terminal 301 Touch panel 302 Communication module 303 Control device 304 Two-dimensional code reader

Claims (13)

A user terminal operated by the user, a visited terminal installed at the visited destination visited by the user, and a process for determining whether or not the user can enter the visited destination as a countermeasure against infectious diseases are executed. An infectious disease control system in which an infectious disease control device is connected via a communication line.
The user terminal is
A physical condition information input receiving means for receiving input of information related to physical condition from the user,
A health management data transmission means for transmitting the user's health management data including information on the physical condition received by the physical condition information input reception means to the infectious disease control device, and a health management data transmission means.
An antibody test result specifying means for specifying an antibody test result of the infectious disease of the user, and
An antibody test result information transmitting means for transmitting the antibody test result information specified by the antibody test result specifying means to the infectious disease control device, and an antibody test result information transmitting means.
When the output of the admission check information used for determining the admission of the user is instructed, the admission check information requesting means for requesting the infectious disease control device to issue the admission check information, and the admission check information requesting means.
It is provided with an admission check information display means for receiving and displaying the admission check information from the infectious disease control device.
The infectious disease control device is
A health management data recording means that receives the health management data from the user terminal and records it on a storage medium.
An antibody test result information recording means that receives information on the antibody test result from the user terminal and records it on a storage medium.
When the user terminal requests the issuance of the admission check information, the infection risk of the user is determined based on the health management data and the information of the antibody test result, and the user is based on the infection risk. Admission determination means for determining admission to the visited destination, and
It is provided with an admission check information transmitting means for transmitting the admission check information for notifying the admission decision result of the user to the visited place determined by the admission possibility determination means to the user terminal.
The visited terminal is
An admission check information reading means for reading the admission check information displayed on the user terminal, and
An admission availability information display means for displaying information indicating whether or not the user can enter the visited destination based on the admission check information read by the admission check information reading means is provided .
The admission determination means includes risks based on the user's basic information and living information, risks based on contact information with the infected person, risks based on the user's symptoms and vital data, and vaccination and test results of the user. For each risk of risk based on, the user is calculated by calculating a score for determining the infection risk of the user, and comparing the total value of the scores calculated for each risk with a preset threshold value. An infectious disease control system characterized by determining the high risk of infection. In the infectious disease control system according to claim 1,
The antibody test result specifying means is an infectious disease control system characterized in that the antibody test result of the infectious disease of the user is specified based on an image obtained by taking an antibody test kit displaying the test result. In the infectious disease control system according to claim 1 or 2.
The infectious disease countermeasures are characterized in that the admission permission determination means determines that the user cannot enter when the infection risk of the user is high, and determines that the user can enter when the infection risk of the user is low. system. In the infectious disease control system according to any one of claims 1 to 3,
The infectious disease control system is characterized in that the admission determination means determines whether or not the user can enter the visited place in consideration of the result of the antigen test received by the user and the result of the PCR test. In the infectious disease control system according to any one of claims 1 to 4,
The infectious disease control system, characterized in that the admission check information is a two-dimensional code including information indicating a determination result of whether or not the user can enter the visited place. In the infectious disease control system according to claim 5.
The infectious disease control system, wherein the entrance check information reading means reads the entrance check information by reading the two-dimensional code displayed on the user terminal. In the infectious disease control system according to any one of claims 1 to 6,
The user terminal is further provided with an information display means for displaying information on the physical condition of the user and information on the antibody test result in chronological order based on the health management data and the information on the antibody test result. Infectious disease control system. It is an infectious disease control system for determining whether or not a user can enter a visited place based on the infection risk of the user's infectious disease.
A physical condition information input receiving means for receiving input of information related to physical condition from the user,
An antibody test result specifying means for specifying an antibody test result of the infectious disease of the user, and
When the output of the admission check information used for determining the admission of the user is instructed, the infection risk of the user is determined based on the health management data and the information of the antibody test result, and the infection. An admission determination means for determining admission of the user to the visited destination based on the risk, and an admission determination means.
An admission check information issuing means for issuing the admission check information for notifying the admission decision result of the user to the visited place determined by the admission permission determination means, and an admission check information issuing means.
Based on the admission check information issued by the admission check information issuing means, the admission check information display means for displaying information indicating whether or not the user can enter the visited destination is provided .
The admission determination means includes risks based on the user's basic information and living information, risks based on contact information with the infected person, risks based on the user's symptoms and vital data, and vaccination and test results of the user. For each risk of risk based on, the user is calculated by calculating a score for determining the infection risk of the user, and comparing the total value of the scores calculated for each risk with a preset threshold value. An infectious disease control system characterized by determining the high risk of infection. In the infectious disease control system according to claim 8.
The antibody test result specifying means is an infectious disease control system characterized in that the antibody test result of the infectious disease of the user is specified based on an image obtained by taking an antibody test kit displaying the test result. In the infectious disease control system according to claim 8 or 9.
The infectious disease countermeasures are characterized in that the admission permission determination means determines that the user cannot enter when the infection risk of the user is high, and determines that the user can enter when the infection risk of the user is low. system. In the infectious disease control system according to any one of claims 8 to 10.
The infectious disease control system is characterized in that the admission determination means determines whether or not the user can enter the visited place in consideration of the result of the antigen test received by the user and the result of the PCR test. In the infectious disease control system according to any one of claims 8 to 11.
The infectious disease control system, characterized in that the admission check information is a two-dimensional code including information indicating a determination result of whether or not the user can enter the visited place. In the infectious disease control system according to any one of claims 8 to 12.
An infectious disease control system further comprising an information display means for displaying information on the physical condition of the user and information on the antibody test result in chronological order based on the health management data and the information on the antibody test result. ..

Images